Active Not Recruiting NA INTERVENTIONAL 1-arm NCT04380311

Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant

Precision Pharmacokinetic-Guided Tacrolimus Dosing to Improve Pediatric Heart Transplant Outcomes

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Heart Transplant Failure and Rejection

Interventions Tacrolimus Dosing Support Tool

Updated 10 times since 2020 Last updated: Jan 3, 2025 Started: May 1, 2020 Primary completion: Apr 30, 2025 Completion: Apr 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04380311, this NA trial focuses on Heart Transplant Failure and Rejection and remains ongoing. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 10 times since 2020, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Feb 2025 — Present [monthly]

Active Not Recruiting NA
Sep 2024 — Feb 2025 [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2023 — Apr 2024 [monthly]

Recruiting NA

▶ Show 5 earlier versions

Jun 2022 — Jun 2023 [monthly]

Recruiting NA
May 2021 — Jun 2022 [monthly]

Recruiting NA
Jan 2021 — May 2021 [monthly]

Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Recruiting NA
Jun 2020 — Dec 2020 [monthly]

Recruiting NA

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)
University of Utah

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States